Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Perry

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
Annals of the New York Academy of Sciences|January 1, 1991
Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's diseaseE K Perry, I McKeith, P Thompson, et al.
Neuroscience Letters|October 24, 1985
Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetusJ M Candy, E K Perry, R H Perry, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 5, 2003
Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380S L Pimlott, M Piggott, J Owens, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1987
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseasesE K Perry, R H Perry, C J Smith, et al.
Dementia and Geriatric Cognitive Disorders|October 25, 2000
Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's diseaseM P Walker, G A Ayre, E K Perry, et al.
Brain Research. Molecular Brain Research|December 5, 1998
Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer's diseaseS Terzano, J A Court, D Fornasari, et al.
Neuroscience|June 20, 2000
Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medicationJ A Court, M A Piggott, S Lloyd, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 14, 2018
A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of ageN S L Perry, R Menzies, F Hodgson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 2006
Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomographyJ T O'Brien, S J Colloby, S Pakrasi, et al.
Neuroreport|June 27, 1994
Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21)R Raghavan, C Khin-Nu, A G Brown, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
Annals of the New York Academy of Sciences|January 1, 1991
Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's diseaseE K Perry, I McKeith, P Thompson, et al.
Neuroscience Letters|October 24, 1985
Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetusJ M Candy, E K Perry, R H Perry, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 5, 2003
Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380S L Pimlott, M Piggott, J Owens, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1987
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseasesE K Perry, R H Perry, C J Smith, et al.
Dementia and Geriatric Cognitive Disorders|October 25, 2000
Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's diseaseM P Walker, G A Ayre, E K Perry, et al.
Brain Research. Molecular Brain Research|December 5, 1998
Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer's diseaseS Terzano, J A Court, D Fornasari, et al.
Neuroscience|June 20, 2000
Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medicationJ A Court, M A Piggott, S Lloyd, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 14, 2018
A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of ageN S L Perry, R Menzies, F Hodgson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 2006
Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomographyJ T O'Brien, S J Colloby, S Pakrasi, et al.
Neuroreport|June 27, 1994
Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21)R Raghavan, C Khin-Nu, A G Brown, et al.
Pageof 19